In 2023, LigaChem Biosciences completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, LigaChem Biosciences has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020-2019 |
|---|---|---|---|---|
Total Scope 1 | 308a | 372a | 97a | |
Total Scope 2 | ||||
Unspecified Calculation Method | 1,227a | 1,346a | 603a | |
Total Scope 3 | N/A | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 11.5264a | 14.0314a | 3.5892a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2023, the total operational greenhouse gas (GHG) emissions of LigaChem Biosciences amounted to 1,535 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of LigaChem Biosciences decreased by 10.65%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2023, the total Scope 1 emissions of LigaChem Biosciences were 308 metric tons of CO₂ equivalent (tCO₂e).a
Since 2021, LigaChem Biosciences's Scope 1 emissions have increased by 217.53%, reflecting a rising long-term trend in Scope 1 emissions over time.a
Compared to the previous year (2022), LigaChem Biosciences's Scope 1 emissions decreased by 17.2%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2023, LigaChem Biosciences reported Scope 2 greenhouse gas (GHG) emissions of 1,227 tCO₂e without specifying the calculation method.a
Since 2021, LigaChem Biosciences's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 103.48%, reflecting a rising long-term trend in Scope 2 emissions over time.a
Compared to the previous year (2022), LigaChem Biosciences's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that LigaChem Biosciences's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2023, LigaChem Biosciences reported its Scope 2 emissions using an unspecified methodology.a
In 2023, LigaChem Biosciences reported Scope 1 greenhouse gas (GHG) emissions of 308 tCO₂e and total revenues of USD 27 millions. This translates into an emissions intensity of 11.53 tCO₂e per millions USD.a
In 2023, LigaChem Biosciences reported a Scope 1 emissions intensity of 11.53 tCO₂e per millions USD. Compared to the peer group median of 5.9, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2023, LigaChem Biosciences ranked 14 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
LigaChem Biosciences is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a